I was a very early investor in both healthcare and biotech, particularly focusing on early-stage companies looking to utilise the latest advancements in technology to make much-needed breakthroughs in their fields.Heinz Junkermann’s legacy therefore is not simply that of business acumen. His and his family’s support for philanthropy is e… Read More